Current Ratio of MoonLake Immunotherapeutics from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
MoonLake Immunotherapeutics quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • MoonLake Immunotherapeutics Current Ratio for the quarter ending 30 Sep 2025 was 1512%, a 63% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

MoonLake Immunotherapeutics Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1512% -2620% -63% 30 Sep 2025
Q2 2025 2075% -3000% -59% 30 Jun 2025
Q1 2025 2576% -3135% -55% 31 Mar 2025
Q4 2024 3259% -1316% -29% 31 Dec 2024
Q3 2024 4132% +583% +16% 30 Sep 2024
Q2 2024 5076% +2449% +93% 30 Jun 2024
Q1 2024 5711% +4382% +330% 31 Mar 2024
Q4 2023 4575% +4403% +2556% 31 Dec 2023
Q3 2023 3549% +3415% +2553% 30 Sep 2023
Q2 2023 2626% +2528% +2578% 30 Jun 2023
Q1 2023 1329% +1272% +2241% 31 Mar 2023
Q4 2022 172% +114% +194% 31 Dec 2022
Q3 2022 134% -107% -44% 30 Sep 2022
Q2 2022 98% 30 Jun 2022
Q1 2022 57% 31 Mar 2022
Q4 2021 59% 31 Dec 2021
Q3 2021 241% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.